Valneva (VALN) News Today $7.07 -0.36 (-4.85%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 25 at 10:00 AM | prnewswire.comGuggenheim Lowers Valneva (NASDAQ:VALN) Price Target to $15.00Guggenheim lowered their price target on shares of Valneva from $17.00 to $15.00 and set a "buy" rating for the company in a report on Monday.March 25 at 9:42 AM | marketbeat.comValneva Announces Filing of 2024 Universal Registration Document and US Form 20-FMarch 25 at 2:00 AM | globenewswire.comValneva (NASDAQ:VALN) Price Target Lowered to $15.00 at GuggenheimMarch 25 at 1:48 AM | americanbankingnews.comValneva outlays 40,000 vaccines to Réunion amidst chikungunya surgeMarch 24 at 5:08 PM | finance.yahoo.comValneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La RéunionMarch 24 at 7:06 AM | markets.businessinsider.comValneva Responds to French Government's Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La RéunionMarch 24 at 2:00 AM | globenewswire.comValneva (NASDAQ:VALN) Stock Price Up 2.3% - Should You Buy?Valneva (NASDAQ:VALN) Shares Up 2.3% - Here's WhyMarch 22 at 12:32 PM | marketbeat.comHC Wainwright Reiterates Buy Rating for Valneva (NASDAQ:VALN)HC Wainwright reiterated a "buy" rating and set a $17.00 price objective on shares of Valneva in a research report on Friday.March 22 at 8:26 AM | marketbeat.comValneva’s Earnings Call Highlights Robust Growth Amid ChallengesMarch 22 at 1:46 AM | msn.comValneva outlines €170M-€180M sales target for 2025 with focus on IXCHIQ and Lyme vaccine developmentsMarch 21, 2025 | msn.com3VALN : Breaking Down Valneva: 6 Analysts Share Their ViewsMarch 21, 2025 | benzinga.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?Valneva (NASDAQ:VALN) Shares Gap Up - Time to Buy?March 21, 2025 | marketbeat.comValneva (NASDAQ:VALN) Posts Earnings Results, Misses Estimates By $0.32 EPSValneva (NASDAQ:VALN - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.32). Valneva had a negative return on equity of 3.93% and a negative net margin of 4.35%.March 21, 2025 | marketbeat.comValneva SE (INRLF) (FY 2024) Earnings Call Highlights: Strong Sales Growth and Strategic ...March 21, 2025 | gurufocus.comFull Year 2024 Valneva SE Earnings Call TranscriptMarch 21, 2025 | gurufocus.comValneva SE 2024 Q4 - Results - Earnings Call PresentationMarch 20, 2025 | seekingalpha.comValneva (NASDAQ:VALN) Shares Gap Down - Time to Sell?Valneva (NASDAQ:VALN) Shares Gap Down - Here's What HappenedMarch 20, 2025 | marketbeat.comValneva Reports Full Year 2024 Results and Provides Business Updates and OutlookMarch 20, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 17, 2025 | prnewswire.comValneva (VALN) to Release Earnings on WednesdayMarch 17, 2025 | americanbankingnews.comValneva SE (NASDAQ:VALN) Short Interest Down 84.2% in FebruaryValneva SE (NASDAQ:VALN - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 5,800 shares, a decrease of 84.2% from the February 13th total of 36,700 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 59,500 shares, the days-to-cover ratio is presently 0.1 days.March 13, 2025 | marketbeat.comValneva (VALN) Expected to Announce Earnings on WednesdayValneva (NASDAQ:VALN) will be releasing earnings before the market opens on Wednesday, March 19, Financial Modeling Prep reports.March 12, 2025 | marketbeat.comValneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationMarch 11, 2025 | markets.businessinsider.comValneva (NASDAQ:VALN) Shares Gap Up - Here's WhyValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?March 8, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNMarch 4, 2025 | prnewswire.comValneva SE to Present at Key Healthcare Investor ConferencesMarch 3, 2025 | tipranks.comValneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor ConferencesMarch 3, 2025 | globenewswire.comValneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQMarch 2, 2025 | finanznachrichten.deHC Wainwright Reaffirms "Buy" Rating for Valneva (NASDAQ:VALN)HC Wainwright restated a "buy" rating and issued a $17.00 price target on shares of Valneva in a report on Friday.March 1, 2025 | marketbeat.comValneva reports positive CHMP opinion for adolescent label extension for IxchiqMarch 1, 2025 | markets.businessinsider.comValneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®March 1, 2025 | markets.businessinsider.comValneva Gains EMA Support for Chikungunya Vaccine ExtensionFebruary 28, 2025 | tipranks.comValneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®February 28, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Valneva (VALN) and Butterfly Network (BFLY)February 28, 2025 | markets.businessinsider.comCDC investigating hospitalizations of five people who recently received chikungunya vaccineFebruary 27, 2025 | msn.comValneva (NASDAQ:VALN) Shares Gap Up - Should You Buy?Valneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedFebruary 24, 2025 | marketbeat.comHC Wainwright Has Pessimistic Outlook of Valneva Q4 EarningsValneva SE (NASDAQ:VALN - Free Report) - HC Wainwright cut their Q4 2024 earnings estimates for shares of Valneva in a research note issued on Wednesday, February 19th. HC Wainwright analyst E. White now expects that the company will post earnings of ($0.17) per share for the quarter, down from tFebruary 22, 2025 | marketbeat.comKepler Capital Reaffirms Their Buy Rating on Valneva (0OB3)February 20, 2025 | markets.businessinsider.comHC Wainwright Issues Pessimistic Forecast for Valneva (NASDAQ:VALN) Stock PriceHC Wainwright reduced their price objective on Valneva from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday.February 20, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - What's Next?Valneva (NASDAQ:VALN) Shares Gap Up - Time to Buy?February 19, 2025 | marketbeat.comValneva price target lowered to $17 from $18 at H.C. WainwrightFebruary 19, 2025 | markets.businessinsider.comValneva hits 2024 sales target but plans lower cash burn in 2025February 18, 2025 | finance.yahoo.comValneva Reports 2024 Financial Performance and Optimistic 2025 OutlookFebruary 18, 2025 | tipranks.comValneva Expects Further Sales GrowthFebruary 18, 2025 | marketwatch.comValneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 OutlookFebruary 18, 2025 | globenewswire.comValneva (NASDAQ:VALN) Stock Price Down 11.2% - What's Next?Valneva (NASDAQ:VALN) Stock Price Down 11.2% - Here's What HappenedFebruary 15, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?Valneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?February 13, 2025 | marketbeat.comValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's WhyValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's What HappenedFebruary 12, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedFebruary 11, 2025 | marketbeat.com Remove Ads Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.140.62▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼224▲VALN Articles Average Week Remove Ads Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News BLTE News ARWR News CGON News HRMY News ARQT News JANX News TVTX News AGIO News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
